Supplementary Figures 1 - 3 from Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors

Supplementary Figure 1: Differential cytolytic potential and activation of Th17IL-1β cells in culture. Supplementary figure 2: Ectonucleotidase expression and persistence of different Th17 cells. Supplementary figure 3: Schematic summary highlighting the effect of different Th17 programming conditions on anti-tumor function.